Tenax Therapeutics, Inc. (TENX)
NASDAQ: TENX · Real-Time Price · USD
7.34
-0.43 (-5.53%)
Oct 10, 2025, 2:42 PM EDT - Market open

Tenax Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202006 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2006 - 2019
Selling, General & Admin
15.536.795.015.687.585.31
Upgrade
Research & Development
19.5112.713.235.3825.154.56
Upgrade
Total Operating Expenses
35.0419.498.2311.0532.739.87
Upgrade
Operating Income
-35.04-19.49-8.23-11.05-32.73-9.87
Upgrade
Interest Income
4.021.910.48---
Upgrade
Interest Expense
0.040.020.02-0-0-0
Upgrade
Other Non-Operating Income (Expense)
-00.06-0.01-0.25-0.02
Upgrade
Total Non-Operating Income (Expense)
4.061.940.57-0.01-0.26-0.02
Upgrade
Pretax Income
-30.98-17.56-7.66-11.07-32.98-9.89
Upgrade
Net Income
-30.98-17.56-7.66-11.07-32.98-9.89
Upgrade
Net Income to Common
-30.98-17.56-7.66-11.07-32.98-9.89
Upgrade
Shares Outstanding (Basic)
33150000
Upgrade
Shares Outstanding (Diluted)
33150000
Upgrade
Shares Change (YoY)
3438.45%6046.87%1250.92%43.00%98.51%67.31%
Upgrade
EPS (Basic)
-2.88-1.15-31.04-600.71-2524.80-1520.00
Upgrade
EPS (Diluted)
-2.88-1.15-31.04-600.71-2524.80-1520.00
Upgrade
Free Cash Flow
-19.84-14.81-5.9-11.39-10.86-9.28
Upgrade
Free Cash Flow Per Share
-0.59-0.97-23.76-619.25-844.54-1431.84
Upgrade
EBITDA
-35.04-19.49-8.23-10.94-32.62-9.75
Upgrade
EBIT
-35.04-19.49-8.23-11.05-32.73-9.87
Upgrade
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q